0.001
0.00 (0.00%)
| Penutupan Terdahulu | 0.001 |
| Buka | 0.001 |
| Jumlah Dagangan | 24,764 |
| Purata Dagangan (3B) | 96,294 |
| Modal Pasaran | 14,341 |
| Harga / Buku (P/B) | 1.24 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 15 Nov 2024 - 18 Nov 2024 |
| Margin Operasi (TTM) | -968.04% |
| EPS Cair (TTM) | -3.54 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 150.30% |
| Nisbah Semasa (MRQ) | 0.340 |
| Aliran Tunai Operasi (OCF TTM) | -51.00 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -29.10 M |
| Pulangan Atas Aset (ROA TTM) | -29.15% |
| Pulangan Atas Ekuiti (ROE TTM) | -419.59% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | VBI Vaccines, Inc. (CDA) | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 0.0 |
| Purata | 0.75 |
|
VBI Vaccines Inc., a commercial-stage biopharmaceutical company, develops and sells vaccines to treat immuno-oncology and infectious disease. It offers hepatitis B (HBV) vaccine under the PreHevbrio, PreHevbri, and Sci-B-Vac brand names. The company also develops VBI-2601, a protein based immunotherapeutic candidate for the treatment of chronic HBV infection; VBI-1901, a glioblastoma cancer vaccine immunotherapeutic candidate; VBI-1501, a prophylactic cytomegalovirus vaccine candidate; and VBI-2501 to treat Zika virus. In addition, it develops coronavirus vaccine candidates that include VBI-2902, VBI-2901, and VBI-2905. The company has collaboration and license agreements with Brii Biosciences Limited, the National Research Council of Canada, and Coalition for Epidemic Preparedness Innovations. The company was formerly known as SciVac Therapeutics Inc. and changed its name to VBI Vaccines Inc. in May 2016. VBI Vaccines Inc. is based in Cambridge, Massachusetts. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| % Dimiliki oleh Orang Dalam | 6.77% |
| % Dimiliki oleh Institusi | 3.69% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Baystate Wealth Management Llc | 31 Dec 2023 | 16 |
| Aspen Grove Capital, Llc | 30 Sep 2024 | 0 |
| Community Bank, N.A. | 30 Sep 2024 | 0 |
| City Holding Co | 30 Sep 2024 | 0 |
| Advisornet Financial, Inc | 30 Sep 2024 | 0 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2024 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |